Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 2 | Y014090 | IM / LL |
Patient had seizure like activity in pediatrician office after vaccine was administered (arms raised up and something "in her eye", lasted 15 seconds). Had second episode of seizure like activity at home (similar characteristics but eyes rolled back, lasted 3-5 seconds). Taken to ER. Normal exam in ER with Neurology consulted. Discharged home. Immediately after discharge, patient had third episode of seizure like activity (patient was back arching/eyes deviated to left, increase tone, color change (blue/purple), lasted 7 seconds). Went back into the ER. Fourth episode noted by ER provider (similar characteristics to above instances. Keppra load IV started and transfered to hospital. Hospitalized for 2 days. Imaging and workup done. Discharged home. Started on outpatient Keppra. Set to see PCH Neurology on 7/8/25. Saw pediatrician for ER/Hospitalization follow up on 7/1/25.
None noted
Plagiocephaly, torticollis
None
None, NKDA
Full infectious panel (bloodwork, urine, spinal tap) normal, Ultrasound of head normal, EEG normal